The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
Concurring Statement of Commissioner Rebecca Kelly Slaughter Regarding the Request for Comment on the Funeral Rule
Agency Information Collection Activities; Proposed Collection; Comment Request; Extension (Funeral Rule)
Agency Information Collection Activities; Submission to the Office of Management and Budget for Review and Approval; Comment Request (Regulation O)
16 CFR Part 453: Trade Regulation Rule on Funeral Industry Practices; Request for Comments
2002002 Informal Interpretation
Concurring Statement of Commissioner Rebecca Kelly Slaughter in the Matter of Shop Tutors, Inc. d/b/a LendEDU
Joint FDA-FTC Statement Regarding Collaboration to Advance Competition in the Biologic Marketplace
T&M Protection Resources, LLC; Analysis To Aid Public Comment
Click Labs, Inc., In the Matter of
Click Labs, Inc. settled Federal Trade Commission allegations that the company made false claims in connection with the EU-U.S. Privacy Shield framework.
Global Data Vault, LLC, In the Matter of
Global Data Vault, LLC, settled Federal Trade Commission allegations that the company made false claims in connection with the EU-U.S. Privacy Shield framework.
Incentive Services, Inc., In the Matter of
Incentive Services, Inc., settled Federal Trade Commission allegations that the company made false claims in connection with the EU-U.S. Privacy Shield framework, which enables companies to transfer consumer data legally from European Union countries to the United States.
TDARX, Inc., In the Matter of
TDARX, Inc., settled Federal Trade Commission allegations that the company made false claims in connection with the EU-U.S. Privacy Shield framework.
85 FR 4984
20191560: PBF Energy Inc.; Royal Dutch Shell plc
Illumina Inc./Pacific Biosciences of California, Inc., In the Matter of
The Federal Trade Commission authorized an action to block Illumina Inc.’s proposed $1.2 billion acquisition of Pacific Biosciences of California, alleging in an administrative complaint that Illumina is seeking to unlawfully maintain its monopoly in the U.S. market for next-generation DNA sequencing systems by extinguishing PacBio as a nascent competitive threat. The Commission vote to issue the administrative complaint and to authorize staff to seek a temporary restraining order and preliminary injunction was 5-0. On Jan. 2, 2020, the parties abandoned the transaction.